Emanuela Romano

Emanuela Romano is an Italian Paralympic swimmer who competes in international level events. She has won three medals at the 2013 IPC Swimming World Championships in Montreal, a bronze medalist at the 2016 IPC Swimming European Championships and has competed at the 2012 and 2016 Summer Paralympics. She also holds the Italian record for the 100m backstroke in her sports category. Provided by Wikipedia
Showing 1 - 16 results of 16 for search 'Emanuela Romano', query time: 0.05s Refine Results
  1. 1
    Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts

    Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts by Eleonora Timperi, Emanuela Romano, Emanuela Romano

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid Tumors

    Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid Tumors by Marion Alcantara, Pauline Du Rusquec, Emanuela Romano

    Published 2020-01-01
    Get full text
    Article
  3. 3
    Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial

    Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial by Sandra Demaria, Emanuela Romano, Muriel Brackstone, Silvia C. Formenti

    Published 2019-11-01
    Get full text
    Article
  4. 4
    Immunotherapy in breast cancer: an overview of current strategies and perspectives

    Immunotherapy in breast cancer: an overview of current strategies and perspectives by Véronique Debien, Alex De Caluwé, Xiaoxiao Wang, Martine Piccart-Gebhart, Vincent K. Tuohy, Emanuela Romano, Laurence Buisseret

    Published 2023-02-01
    Get full text
    Article
  5. 5
    Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.

    Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients. by Emanuela M Iancu, Philippe O Gannon, Julien Laurent, Bhawna Gupta, Pedro Romero, Olivier Michielin, Emanuela Romano, Daniel E Speiser, Nathalie Rufer

    Published 2013-01-01
    Get full text
    Article
  6. 6
    Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges

    Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges by Xiaoxiao Wang, Laetitia Collet, Mattia Rediti, Véronique Debien, Alex De Caluwé, David Venet, Emanuela Romano, Françoise Rothé, Christos Sotiriou, Laurence Buisseret

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Predictors of recovering ambulation after hip fracture inpatient rehabilitation

    Predictors of recovering ambulation after hip fracture inpatient rehabilitation by Francesca Cecchi, Silvia Pancani, Desiderio Antonioli, Lucia Avila, Manuele Barilli, Massimo Gambini, Lucilla Landucci Pellegrini, Emanuela Romano, Chiara Sarti, Margherita Zingoni, Maria Assunta Gabrielli, Federica Vannetti, Guido Pasquini, Claudio Macchi

    Published 2018-08-01
    Get full text
    Article
  8. 8
    Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

    Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer by Hugo Croizer, Rana Mhaidly, Yann Kieffer, Geraldine Gentric, Lounes Djerroudi, Renaud Leclere, Floriane Pelon, Catherine Robley, Mylene Bohec, Arnaud Meng, Didier Meseure, Emanuela Romano, Sylvain Baulande, Agathe Peltier, Anne Vincent-Salomon, Fatima Mechta-Grigoriou

    Published 2024-04-01
    Get full text
    Article
  9. 9
    347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of 22 months of follow-up

    347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of... by Urban Emmenegger, Howard Gurney, Emanuela Romano, Neal Shore, Margitta Retz, Christian Poehlein, Charles Schloss, Leonard Appleman, Gwenaelle Gravis, Loïc Mourey, Josep Piulats, Evan Yu, Johann De Bono, William Berry, Peter Fong, Cristiano Ferrario, Tilman Todenhoefer, Henry Conter, Brigitte Laguerre, Xin Tong Li

    Published 2021-11-01
    Article
  10. 10
    First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

    First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in pha... by Martine Piccart-Gebhart, Emanuela Romano, Christos Sotiriou, Marianne Paesmans, Ligia Craciun, Denis Larsimont, Roberto Salgado, Elisa Agostinetto, Laurence Buisseret, Isabelle Veys, Alex de Caluwé, Philip Poortmans, Guilherme Nader Marta, Zoe Denis, Stylianos Drisis, Christophe Vandekerkhove, Antoine Desmet, Catherine Philippson, Dirk Van Gestel, Michail Ignatiadis

    Published 2023-12-01
    Get full text
    Article
  11. 11
    Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma

    Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma by Natacha Bordry, Maria A. S. Broggi, Kaat de Jonge, Karin Schaeuble, Philippe O. Gannon, Periklis G. Foukas, Esther Danenberg, Emanuela Romano, Petra Baumgaertner, Manuel Fankhauser, Noémie Wald, Laurène Cagnon, Samia Abed-Maillard, Hélène Maby-El Hajjami, Timothy Murray, Kalliopi Ioannidou, Igor Letovanec, Pu Yan, Olivier Michielin, Maurice Matter, Melody A. Swartz, Daniel E. Speiser

    Published 2018-08-01
    Get full text
    Article
  12. 12
    Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

    Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial by Manuel Rodrigues, Giulia Vanoni, Pierre Loap, Coraline Dubot, Eleonora Timperi, Mathieu Minsat, Louis Bazire, Catherine Durdux, Virginie Fourchotte, Enora Laas, Nicolas Pouget, Zahra Castel-Ajgal, Gregoire Marret, Laetitia Lesage, Didier Meseure, Anne Vincent-Salomon, Lolita Lecompte, Nicolas Servant, Sophie Vacher, Ivan Bieche, Caroline Malhaire, Virginie Huchet, Laurence Champion, Maud Kamal, Sebastian Amigorena, Olivier Lantz, Marion Chevrier, Emanuela Romano

    Published 2023-06-01
    Get full text
    Article
  13. 13
    Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

    Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast ca... by Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Francois P. Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine Piccart-Gebhart

    Published 2023-12-01
    Get full text
    Article
  14. 14
    Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

    Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomize... by Laurence Buisseret, Delphine Loirat, Philippe Aftimos, Christian Maurer, Kevin Punie, Véronique Debien, Paulus Kristanto, Daniel Eiger, Anthony Goncalves, François Ghiringhelli, Donatienne Taylor, Florent Clatot, Tom Van den Mooter, Jean-Marc Ferrero, Hervé Bonnefoi, Jean-Luc Canon, Francois P. Duhoux, Laura Mansi, Renaud Poncin, Philippe Barthélémy, Nicolas Isambert, Zoë Denis, Xavier Catteau, Roberto Salgado, Elisa Agostinetto, Evandro de Azambuja, Françoise Rothé, Ligia Craciun, David Venet, Emanuela Romano, John Stagg, Marianne Paesmans, Denis Larsimont, Christos Sotiriou, Michail Ignatiadis, Martine Piccart-Gebhart

    Published 2023-11-01
    Get full text
    Article
  15. 15
    Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries

    Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries by Joan Brunet, Josep Tabernero, Salvatore Grisanti, Matteo Lambertini, George Pentheroudakis, Bruno Vincenzi, Dirk Arnold, Juan Aguilar-Company, Paolo Pedrazzoli, Solange Peters, Luis Castelo-Branco, Emanuela Romano, Olivier Michielin, Ramon Salazar, Alessio Cortellini, Rossana Berardi, Aleix Prat, Spyridon Gennatas, Giuseppe Tonini, Urania Dafni, Kevin J Harrington, Paola Queirolo, David J Pinato, Francesca Mazzoni, David Viñal, Gino M Dettorre, Uma Mukherjee, Mark Bower, Alexia Bertuzzi, Ailsa Sita-Lumsden, Federica Biello, Andrea Patriarca, Alessandra Gennari, Maura Rossi, Zoi Tsourti, Vasileios Angelis, Jacobo Rogado, Teresa Alonso-Gordoa, Georgia Dimopoulou, Sylvain Pradervand, Marco Tucci, Fanny Pommeret, Marco Krengli

    Published 2022-11-01
    Get full text
    Article
  16. 16
    An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves

    An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves by Oskar Wysocki, Cong Zhou, Jacobo Rogado, Prerana Huddar, Rohan Shotton, Ann Tivey, Laurence Albiges, Angelos Angelakas, Dirk Arnold, Theingi Aung, Kathryn Banfill, Mark Baxter, Fabrice Barlesi, Arnaud Bayle, Benjamin Besse, Talvinder Bhogal, Hayley Boyce, Fiona Britton, Antonio Calles, Luis Castelo-Branco, Ellen Copson, Adina Croitoru, Sourbha S. Dani, Elena Dickens, Leonie Eastlake, Paul Fitzpatrick, Stephanie Foulon, Henrik Frederiksen, Sarju Ganatra, Spyridon Gennatas, Andreas Glenthøj, Fabio Gomes, Donna M. Graham, Christina Hague, Kevin Harrington, Michelle Harrison, Laura Horsley, Richard Hoskins, Zoe Hudson, Lasse H. Jakobsen, Nalinie Joharatnam-Hogan, Sam Khan, Umair T. Khan, Khurum Khan, Alexandra Lewis, Christophe Massard, Alec Maynard, Hayley McKenzie, Olivier Michielin, Anne C. Mosenthal, Berta Obispo, Carlo Palmieri, Rushin Patel, George Pentheroudakis, Solange Peters, Kimberly Rieger-Christ, Timothy Robinson, Emanuela Romano, Michael Rowe, Marina Sekacheva, Roseleen Sheehan, Alexander Stockdale, Anne Thomas, Lance Turtle, David Viñal, Jamie Weaver, Sophie Williams, Caroline Wilson, Caroline Dive, Donal Landers, Timothy Cooksley, André Freitas, Anne C. Armstrong, Rebecca J. Lee, on behalf of the ESMO Co-Care

    Published 2022-08-01
    Get full text
    Article

Search Tools: